May 24, 2013 |
PRWeb
Icahn School of Medicine at Mount Sinai
Grants Exclusive License to Cellular
Dynamics International for Development
of a Cellular Therapy for Cardiac Muscles
|
 |
May 1, 2013 |
GEN
Human iPSC-Derived Hepatocytes:
Functional Model Tissue for In Vitro Predictive Metabolism, Toxicity, and Disease Modeling
|
|
Apr, 2013 |
European Pharmaceutical Review
Cell-based Assays for Screening
|
|
Apr, 2013 |
European Pharmaceutical Review
Stem Cell Roundtable
(registration required) |
|
Apr 5, 2013 |
Foundation Fighting Blindness
Stem Cell Pioneers Creating Retinal
Patch to Restore Vision
|
|
Feb 28, 2013 |
SciBX Science-Business Exchange
Cardiomyocytes Acting Like Adults
(subscription required)
|
|
Feb 21, 2013 |
SciBX Science-Business Exchange
Small Molecules vs. Teratomas
(subscription required)
|
|
Jan 29, 2013 |
AstraZeneca LabTalk
Guest post: Human induced pluripotent
stem cell technology |
|
Jan, 2013 |
European Biopharmaceutical Review
Patient in a Dish
|
|
Jan 18, 2013 |
ABC News Nightline
A Nightline news story by Bill Weir
notes CDI's ability to produce billions
of cardiomyocytes. |
|
Jan 15, 2013 |
GEN
New Technological Advances in
Stem Cell Research |
|
Jan 12, 2013 |
The Economist
Potent Medicine: Stem Cells May Transform
the Development of New Drugs |
|
Jan 5, 2013 |
MedNous
AZ in iPS cell deal with Cellular Dynamics
(subscription required) |
|
Dec 1, 2012 |
The Scientist
MyCell Products named Top 10
Innovations for 2012 |
|
Nov 19, 2012 |
Inc.
Manufacturing Cells by the Billions |
|
Nov 2, 2012 |
GEN
In Vitro Clinical Trials: Not that Far-Fetched |
|
Oct 15, 2012 |
Instrument Business Outlook
Partnerships Advance iPSC Research Tools
(subscription required) |
|
Oct, 2012 |
BioPharmaceutiques:
Cellules souches: Les iPS investissent les labos
(published in French) |
|
Oct 1, 2012 |
Clinical Leader:
Increased Adoption of iPSC-derived Human Cells for Use In Drug Discovery and Toxicity Testing(registration required) |
|
Sep 2012 |
Healthcare Global:
Cellular Dynamics International Revolutionizes Our Approach to Health (page 342) |
|
Sep 2012 |
Business Review North America:
Cellular Dynamics International Revolutionizes Our Approach to Health (page 756)
|
|
Sep 7, 2012 |
Genetic Engineering & Biotechnology News (GEN):
Closing the Research Therapeutic Loop
|
|
Aug 10, 2012 |
Drug Discovery & Development:
Bringing Stem Cells to the Forefront
|
|
Aug 2012 |
Nature Reviews Drug Discovery:
Overtaking the DILI Model-T
(subscription required)
|
|
Summer 2012 |
Drug Discovery World:
The Application of iPS Cells and Differentiated Neuronal Cells to Advance Drug Discovery
|
|
Jul 2, 2012 |
Genetic Engineering & Biotechnology News (GEN):
Top 8 Tips for Culturing and Using iPSC-derived Cell Types
|
|
Jun 21, 2012 |
Science-Business eXchange (SciBX):
Reining in Pain
(subscription required)
|
|
Apr 15, 2012 |
Genetic Engineering and Biotechnology News (GEN):
Human iPSC-derived Cardiomyocytes
|
|
Apr 2012 |
Fast Company:
Top 10 Biotech |
|
Apr 3, 2012 |
Wisconsin State Journal:
Madison Researchers Making Major Breakthroughs in Stem Cell Work |
|
Mar 2012 |
American Society for Cell Biology (ASCB):
Advances in Stem-Cell Technology
(subscription required)
|
|
Mar 26, 2012 |
BioCentury:
iPS Predicting Toxicity
(subscription required)
|
|
Mar 13, 2012 |
Newswise:
Scientists Produce Eye Structures from Human Blood-Derived Stem Cells
|
|
Mar 9, 2012 |
MarketWatch:
New Industry Partnership to Strengthen Regenerative Medicine Industry in Canada
|
|
Mar 2012 |
PharmaVoice:
Achieving Value from Discovery and Preclinical Endeavors
|
|
Feb 2012 |
Technology Review:
The 50 Most Innovative Companies in 2012
|
|
Feb 2012 |
Tecan Journal:
Capturing the 'Dynamics' of Automated Cell Culturing
|
|
Jan 1, 2012 |
Genetic Engineering & Biotechnology News (GEN):
Industrial Quantities of iPSCs Now Possible
|
|
Dec 13, 2011 |
Next Big Future:
Stem Cells Will Soon Be Harvested to Create Any Type of Human Cell
|
|
Dec 1, 2011 |
Science-Business eXchange (SciBX):
Stem Cell Jackpot for
Parkinson's Disease
|
|
Nov 14, 2011 |
Bloomberg Government:
Swap of Rats for Human Cells Sought to Speed U.S. Drug Reviews (subscription required)
|
|
Fall 2011 |
Drug Discovery World:
Stem Cell Technology – Delivering the Promise
|
|
Nov 2011 |
Nature Methods:
Neurons from Reprogrammed Cells
|
|
Oct 17, 2011 |
Wall Street Journal:
2011 Technology Innovation Awards
|
|
Oct 17, 2011 |
Wall Street Journal:
Making Heart Cells—Billions of Them
|
|
Oct 10, 2011 |
Stembook:
The Evolving Regenerative Medicine Business Model; Concept and Funding
|
|
Sep 2011 |
Drug Discovery News:
Stem Cell Research: Staking a Claim
|
|
Sep 2011 |
MedNous:
iPSCs and the Future of Personalised Medicine
|
|
Aug 25, 2011 |
Bioscience Technology:
Simplifying Stem Cell Research
|
|
Aug 23, 2011 |
Technology Review:
Growing Heart Cells Just for You
|
|
Aug 1, 2011 |
Scrip:
US Capitol Capsule: Court Rulings in Gene Patent, Stem Cell Cases Provide New Hope for Biopharma
|
|
Aug 1, 2011 |
Drug Discovery & Development:
The Human Element in Toxicity Testing
|
|
Jul 28, 2011 |
BioWorld Today:
Challenge to Federal Funding of Stem Cell Research Fails
(subscription required)
|
|
Jul 14, 2011 |
BioTechniques:
Don't You Know That You're Toxic?
|
|
Jun 27, 2011 |
Financial Times:
Stem Cells: Labs Busy As Projects Reach Early Clinical Trial
|
|
May 26, 2011 |
Science-Business eXchange (SciBX):
iPS Cells: Five Years Later
(subscription required)
|
|
May 15, 2011 |
Genetic Engineering & Biotechnology News (GEN):
Demand Escalates for iPSC Life Science Tools
|
|
May 1, 2011 |
Genetic Engineering & Biotechnology News (GEN):
Human Stem Cell-derived in vitro Model
|
|
Apr 7, 2011 |
Milwaukee Journal Sentinel:
Cellular Dynamics Raises $30 Million
|
|
Apr 2011 |
European Biopharmaceutical Review:
Stem Cell Innovation
|
|
Mar/Apr 2011 |
SP2:
Stem Cell Technology Improves Discovery Hit Rates
|
|
Mar/Apr 2011 |
Technology Review:
The 50 Most Innovative Companies 2011
|
|
Mar 14, 2011 |
Chemical & Engineering News:
Stem Cell Surge: Cellular Dynamics, a Pioneer in Induced Pluripotent Stem Cells, Is Creating a New Services Sector
|
|
Mar 1, 2011 |
BioPharm International:
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
|
|
Winter 2010/11 |
Drug Discovery World:
Induced Pluripotent Stem Cells: A Model for Transforming Drug Discovery
|
|
Jan 2011 |
Nature Methods:
Screening: The Age of Fishes
|
|
Jan 5, 2011 |
PR Newswire:
Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells
|
|
Jan 4, 2011 |
Manufacturing Digital:
Cellular Dynamics International Makes Waves in the Stem Cell Industry
|
|
Dec 1, 2010 |
The Scientist:
Top 10 Innovations 2010
|
|
Nov 26, 2010 |
Science:
Stem Cells for Sale
|
|
Nov 18, 2010 |
Scrip:
Cellular Dynamics Aiming for iPS Cell-based "in vitro Clinical Trials"
|
|
Nov 9, 2010 |
Journal of Cardiovascular Translational Research:
Stem Cells and Their Derivatives: A Renaissance in Cardiovascular Translational Research
|
|
Oct 15, 2010 |
Genetic Engineering News:
Stem Cell Research Perseveres in the Midst of Funding Crisis: Uncertainty Surrounding Federal Grants for hESC Research Advances iPSCs
|
|
Sep 23, 2010 |
National Public Radio: Tech Nation:
Manufacturing Heart Cells and the Benefits of Tobacco Plant
|
|
Sep 23, 2010 |
Bloomberg Businessweek:
Stem Cells That Save Big Pharma a Bundle
|
|
July 1, 2010 |
Genetic Engineering News:
Pharma's R&D Focus Shifting to Stem Cells
|
|
June 2010 |
Drug Discovery:
Induced Pluripotent Stem Cells - A New Wave of Tools for Drug Discovery (pg 42-43)
Applying Pluripotent Stem Cells in Drug Discovery (pg 18-22) |
|
June 2010 |
Nature Biotechnology:
Burgeoning Stem Cell Product Market Lures Major Suppliers (subscription required) |
|
June 2010 |
Tecan Journal:
New Tools for Drug Discovery (page 14) |
|
May 18, 2010 |
Financial Times:
Stem Cells, the Flu Pandemic and Rising Carbon Dioxide Levels (Podcast) |
|
May 15, 2010 |
Genetic Engineering News:
iPSC-derived Human Cardiomyocytes:
Stem Cell Technology Can Facilitate Quick & Early Failure of Toxic or Ineffective NCEs
|
|
May 5, 2010 |
BioWorld:
'Game Changing' iPS Cells Move from Science to Marketplace |
|
May 4, 2010 |
The Times:
New Stem Cells Will Reduce the Need for Animal Testing |
|
May 3, 2010 |
BioCentury:
Heartbeats in a Dish (subscription required) |
|
May 2010 |
MIT Technology Review:
10 Emerging Technologies 2010
Engineered Stem Cells: Mimicking Human Disease in a Dish |
|
Mar 2010 |
Start-Up:
Stem Cells as Research and Discovery Tools (subscription required)
|
|
Mar 1, 2010 |
Pharmaceutical Technology:
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing
|
|
Jan 25, 2010 |
Discover Magazine: Top 100 Stories of 2009:
#4: Stem Cell Science Takes Off
|
|
Jan 25, 2010 |
MIT Technology Review:
The Experimental Man: Company Will Reverse-engineer My Cells
|
|
Jan 22, 2010 |
MIT Technology Review:
Made-to-Order Heart Cells:
Stem Cell Advance Will Help Drug Development
|
|
Jan 2010 |
CDI Founder Tim Kamp lands in "2009 Top Ten Research Advances in Cardiovascular Disease & Stroke," compiled by the American Heart Association. (See "Functional cardiomyocytes derived from human induced pluripotent stem cells") |
 |
Jan 2010 |
Nature Methods:
IPSCs: One Cell to Rule Them All? |
|
Jan 4, 2010 |
BioCentury:
Celling Cardiotox in a Dish (subscription required) |
|
Dec 1, 2009 |
In Business Magazine:
Bios Excel at Science, but Face Funding Dip |
|
Sep 2009 |
Radio Broadcast - Madison1670:
In Business with Jody & Joan, Interview with Chris Kendrick-Parker, CDI Chief Commercial Officer |
|
Sep 2009 |
Forbes:
Growing Diseases in a Dish: A New Kind of Stem Cell Could Vastly Improve Drug Development |
|
Aug 2009 |
Drug Discovery News:
Let It Bleed |
|
Jul 2009 |
Fox 47 WMSN TV
News:
Stem Cells from Blood Cells
See the Video Coverage |
|
Jul 2009 |
The Scientist:
Success with iPSCs |
|
Jun 24, 2009 |
Financial Times:
An Industry to Grow |
|
May 1, 2009 |
Genetic Engineering News:
Identifying Cardiotoxic Compounds |
|
Mar 23, 2009 |
Fortune:
Wisconsin: A State of Innovation |
|
Feb 2009 |
The Scientist:
Profiting from Pluripotency (subscription required) |
|
Feb 2009 |
Promega Cell Notes, Issue 23:
Use of Pluripotent Stem Cell-Derived Cardiomyocytes to Understand Mechanisms of Cardiotoxic Compounds |
|
Nov 29, 2008 |
Milwaukee Journal Sentinel:
Heartbeat of a New Industry: Madison Company Seeks Stem Cell Forefront |
|
Fall 2008 |
Wisconsin Academy of Sciences Arts & Letters:
Wisconsin People & Ideas: Something New from Stem Cells - An Industry |
|
Jun 16, 2008 |
Forbes:
Stem Cells Get Real: Fixing Pharma |
|
May 28, 2008 |
Forbes:
The Man Behind Embryonic Stem Cells |
|
Jan 2008 |
Time Magazine:
The 2008 Time 100 World's Most Influential People: Scientists and Thinkers |
|
Aug 20, 2001 |
Time Magazine:
Stem Winder |
 |
